Medications

FTC accuses Endo, other drugmakers of antitrust violations

The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain treatments.

Neuroscience

New memory test bridges gap between human and animal research

Clinical scientists at the University of California, San Francisco (UCSF) Memory and Aging Center have teamed up with preclinical researchers at the Gladstone Institutes to advance Alzheimer's disease research by developing ...

Medications

FDA OKs first generic for Gleevec leukemia pill

U.S. regulators have approved the first generic version of one of the first very effective—and expensive—cancer drugs, Gleevec, which costs about $10,000 a month.

Medications

California court sides with consumers in generic drug fight

In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...

Medications

First generic Abilify approved

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

Medications

Generic form of nexium approved

(HealthDay)—The first generic version of the heartburn drug Nexium (esomeprazole) has been approved by the U.S. Food and Drug Administration.

Medications

FDA: Ziprasidone can cause rare, serious adverse drug reaction

(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and Drug Administration ...

page 7 from 15